Countries citing scholars working at National Medical Products Administration
Since Specialization
Citations
This map shows the geographic impact of research produced by authors working at National Medical Products Administration. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at National Medical Products Administration with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites National Medical Products Administration more than expected).
Fields of papers published by authors at National Medical Products Administration
This network shows the impact of papers affiliated with National Medical Products Administration at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with National Medical Products Administration at the time of their publication.
About National Medical Products Administration
In recent decades, authors affiliated with National Medical Products Administration have published 2.7k papers, which have received a total of 37.5k indexed citations . Scholars at this organization have produced 149 papers in Pharmacology, 123 papers in Complementary and alternative medicine, 237 papers in Oncology, 191 papers in Immunology and 639 papers in Molecular Biology on the topics of Traditional Chinese Medicine Analysis (63 papers), Analytical Chemistry and Chromatography (58 papers), Advanced biosensing and bioanalysis techniques (53 papers), Nanoplatforms for cancer theranostics (53 papers), Peptidase Inhibition and Analysis (52 papers), Bone Tissue Engineering Materials (50 papers), Radiopharmaceutical Chemistry and Applications (48 papers) and RNA Interference and Gene Delivery (48 papers). Their work is cited by papers focused on Pharmacology (2.0k citations), Molecular Medicine (1.1k citations), Biomaterials (2.8k citations), Complementary and alternative medicine (1.2k citations) and Toxicology (479 citations). Authors at National Medical Products Administration collaborate with scholars in China, United States and United Kingdom and have published in prestigious journals including Plastic & Reconstructive Surgery, Frontiers in Pharmacology, Journal of Pharmaceutical and Biomedical Analysis, Frontiers in Immunology and Molecular Pharmaceutics. Some of National Medical Products Administration's most productive authors include Qiang-min Xie, Qiang Ao, Jianzhong Shen, Shuangyang Ding, Bing He, Xueqing Wang, Qiang Zhang, Kui Zhu, Wenbing Dai and Hengtong Zhang.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.
Explore institutions with similar magnitude of impact